Concepedia

Publication | Open Access

FDA‐approved carbonic anhydrase inhibitors reduce amyloid β pathology and improve cognition, by ameliorating cerebrovascular health and glial fitness

DOIFull Paper Access

34

Citations

98

References

2023

Year

Elisa Canepa, Rebecca Parodi‐Rullán, Rafael Vázquez‐Torres, Begona Gamallo‐Lana, Roberto A Guzman‐Hernandez, Nicole L Lemon, Federica Angiulli, Ludovic Debure, Marc A. Ilies, Leif Østergaard,
Alzheimer s & Dementia

Abstract

This work substantiates the potential application of CAIs in clinical trials for AD and CAA.

References

YearCitations

Page 1